1: Interim Analysis of a Phase II Multi-Institution Randomized, Placebo-Controlled Trial, The Premium Trial (Prevention of Metabolic Syndrome and Increased Weight Using Metformin Concurrent to Androgen Deprivation Therapy and Radiotherapy for Locally Advanced Adenocarcinoma of the Prostate)